Furthermore, the high-frequency mutated genes in the American population fell within the screening range recommended by the NCCN guidelines, while the high-frequency mutated genes, MC1R, PRKDC, and KIF1B in the Chinese ovarian cancer cohort were not covered. The gene discussed is PRKDC; the disease is ovarian carcinoma.